INS and type 2 diabetes mellitus: The association between inflammation and T2D and the idea that anti-inflammatory compounds might be potential antidiabetic leads [4,5,6], prompted us to investigate the ability of EPVA and DHVA to modulate insulin secretion from pancreatic β-cells.